Sommer K Castro
发表
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate
K. Loeb,
S. Meshinchi,
M. Loken,
2022,
Blood advances.
K. Loeb,
S. Meshinchi,
M. Loken,
2023,
Blood advances.